Research news
Our latest round of grants fund projects which aim to improve everyday life for people living with Parkinson’s, without the need for extra medications.
A further trial of a device-delivered GDNF is not going ahead, but other approaches are showing promise.
Predict-PD is a study that aims to understand the risk factors of Parkinson’s. More than 10,000 people are now taking part and are representative of the ethnic diversity within the UK population.
Leading scientists and patient organisations have worked together to develop a framework for using 2 tests to identify Parkinson’s in clinical trials.
The first participant has been recruited to a pioneering Parkinson’s UK funded clinical trial for people with a sleep behaviour disorder who are at a higher risk of developing Parkinson’s.
Studies will investigate the role of inflammation in the brain in Parkinson’s and test whether a new approach to reduce brain inflammation could potentially treat the condition.
Earlier this year we launched a campaign to highlight the importance of taking part in Parkinson’s research. Thanks to your support we’ve seen an encouraging boost in recruitment to vital clinical studies.
A new blood test for a toxic protein may help detect Parkinson’s long before symptoms show.
Researchers add to existing evidence that vitamin B3 may help slow down the progression of Parkinson's.
A study in people with Parkinson’s has found that a vaccine can help slow down clumping of a protein known to be linked to the condition.